Wydawnictwo medyczne Cornetis

Medical publisher

+48 71/ 792 80 77 sekretariat@cornetis.pl

Offer for publishers - CORPRESS SYSTEM

Articles

Title: Cardioprotective actions of erythropoietin - are we ready for clinical application?

Author:
Mateusz ?piewak, Krzysztof J. Filipiak
Type:
Review articles
Language:
PL
Journal:
Polish Journal of Cardiology
Year:
2005
Volume:
7
Number:
6
Start page:
541
Final page:
543
ISSN:
1507-5540
Keywords:
erythropoietin, cardioprotective actions, pleiotropic actions
Read

Erythropoietin (EPO) has a well established role in treating anemia associated with chronić renal failure, in patients receiving chemotherapy, in zidovudine-treated HIV-infected patients. Sińce the discovery of new actions of EPO beyond erythropoiesis, a continuous increase in the number of works concerning cytopro-tective action of EPO has been observed. EPO is known to stimulate angiogenesis, promotes progenitor celi mobilization and proliferation. Basic science research to establish molecular mechanism and experimen-tal research to prove various hypothesis on animal models of nervous system and heart injury are prefor-med. Most of the results are optimistic also in so far the only study on humans. EPO administration in an acute phase of myocardial infarction or stroke might be an innovative way of treatment. However, uncerta-inty remains regarding possibleadresseeffects, in particular- prothrombotic action. Nonerythropoietic de-rivatives of erythropoietin are known. Further studies on their safety and efficiency are warranted.